A Study Protocol for Research Investigating How Geriatric Risk Assessment and Shared Decision-making Conversations Affect Treatment Decisions and Quality of Life in Patients Eligible for Open-heart Surgery.

Last updated: September 24, 2024
Sponsor: University Medical Center Groningen
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cardiac Surgery

Treatment

Geriatric assessment

Shared decision-making conversation

Clinical Study ID

NCT06616129
RR number: 202100724
  • Ages > 70
  • All Genders

Study Summary

The goal of this study is to determine whether intervention by the PRIME clinic influences cardiac treatment decisions, as well as patients quality of life and healthcare utilization.

The main questions this study aims to answer are:

  • Does PRIME consultation influence treatment recommendations?

  • Does a personalized treatment plan for cardiac patients influence health-related quality of life?

  • Does a personalized treatment plan influence healthcare costs (in terms of quality-adjusted life years)?

Participants will:

  • Visit the PRIME clinic once

  • Complete quality of life questionnaires twice

  • Track their healthcare usage over the course of a year and complete a corresponding questionnaire four times.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 70 years and older

  • Eligible for cardiac surgery

  • Having two or more risk factors: stroke; reduced cognitive function; ChronicObstructive Pulmonary Disease (COPD); obesity; reduced left ventricular ejectionfraction; renal failure; reduced mobility; cardiac reoperation; and the complexityof the procedure.

Exclusion

Exclusion Criteria:

  • Unable to read or understand Dutch

Study Design

Total Participants: 70
Treatment Group(s): 2
Primary Treatment: Geriatric assessment
Phase:
Study Start date:
April 04, 2022
Estimated Completion Date:
December 31, 2025

Study Description

The primary outcome of this study is the difference between treatment recommendations; the first treatment recommendation (the decision before the patient visits the outpatient clinic) will be compared with the treatment recommendation after the assessment at the outpatient clinic.

Secondary and other outcomes that will be collected are baseline demographic data including age, gender, body mass index, education level, European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) and co-morbidities such as stroke, reduced cognitive function, chronic obstructive pulmonary disease (COPD) GOLD III or IV, renal failure (a reduced renal function prior to surgery with a kreatinine level ≥150mmol/L), a reduced left ventricular function, reduced mobility, cardiac reoperation and type of surgical procedure (CABG, valve replacement or repair, surgery of the thoracic aorta or a combination of several procedures).

Data will be collected using several questionnaires:

  • Health-related Quality of Life (the RAND-36 questionnaire)

  • The Katz Index of Independence in Activities of Daily Living to assess functional status

  • The Cognitive Impairment Test

  • The Timed Up and Go Test

  • Outcome Prioritization Tool to assess the most important goals of treatment The RAND-36 and KATZ-ADL will be completed by all patients, including those receiving standard care.

Connect with a study center

  • University Medical Center Groningen

    Groningen, Hanzeplein 1 9713 GZ Groningen
    Netherlands

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.